BPA Call 75N91020A00003-75N91021F00001
Award Date
3/24/21
Potential Completion Date
3/23/22
Potential Value
$15K
Federal Agency
National Cancer Institute
Awardee
Department Of Health
Ultimate Awardee
Not listed
NAICS Category
541713 - Research and Development in Nanotechnology
PSC Category
AJ12 - General Science And Technology R&D Services; General Science And Technology; Applied Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health's National Cancer Institute awarded a firm fixed price task order worth $15,281 under an unspecified government-wide acquisition contract vehicle to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The task order calls for linking clinical practice data from the Clinical Practice Research Datalink to the National Cancer Data Registry database to study reproductive risk...
This firm fixed price contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The $185,877.28 contract provides the NCI's Division of Cancer Epidemiology and Genetics (DCEG) with a one-year license to access the Clinical Practice Research Datalink (CPRD) medical records database, which contains...
This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The contract provides the NCI with access to the Clinical Practice Research Datalink (CPRD) database and linkages to the National Cancer Data Registry, to support the NCI's epidemiological cancer research. Specific studies will...
This firm fixed price Blanket Purchase Agreement (BPA) call award from the Department of Health and Human Services' National Institutes of Health's National Cancer Institute provides the prime contractor, the United Kingdom's Department of Health known as the Medicines & Healthcare Products Regulatory Agency, with a license to access the Clinical Practice Research Datalink (CPRD) National Cancer Data Registry (NCDR) database. Valued at one hundred seventy-three thousand one hundred...
This is a firm fixed price contract awarded by the Food and Drug Administration (FDA) to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency (MHRA), a UK government agency. The contract provides the National Institutes of Health's (NIH) National Cancer Institute with access to the UK Clinical Practice Research Datalink (CPRD) database of de-identified patient data, as well as linkages to other registries, to support the agency's epidemiological...
The National Institutes of Health National Cancer Institute awarded a $160,000 firm fixed price Blanket Purchase Agreement Call contract to the Department of Health and Healthcare Products Regulatory Agency for a 12-month license providing access to National Library of Medicine United Kingdom Clinical Practice Research Datalink datasets. The contract has no set-aside designation. Under this contract, the Department of Health and Healthcare Products Regulatory Agency will deliver requested access...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $12,571.47 firm fixed price call against a blanket purchase agreement to the Medicines & Healthcare Products Regulatory Agency, doing business as the Department of Health, located in Great Britain, United Kingdom. The contract is for regulatory services to be delivered by September 22, 2021 in support of the National Cancer Institute's research efforts. No set aside designation...
This is a definitive contract awarded by the Food and Drug Administration (FDA) to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency (MHRA), a UK government agency. The contract, valued at $2,816,500.00, is for the recompete of the General Practice Research Division within the MHRA. It is a firm fixed price contract with no set-aside designation. The contract provides access to the Clinical Practice Research Datalink (CPRD) database and...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...
<p>This is a firm-fixed price purchase order award by the National Institutes of Health (NIH), National Cancer Institute, to the Medicines and Healthcare Products Regulatory Agency. The award, valued at $55,960.57, is for payment related to a prior award with contract number 75N91020A00003. The period of performance runs through July 23, 2024. This award does not have a set-aside designation.</p>